The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment
Open accessAbstract
Tumor-infiltrating T cells often lose their effector function; however, the mechanisms are incompletely understood. We report that cholesterol in the tumor microenvironment induces CD8+ T cell expression of immune checkpoints and exhaustion. Tumor tissues enriched with cholesterol and cholesterol content in tumor-infiltrating CD8+ T cells were positively and progressively associated with upregulated T cell expression of PD-1, 2B4, TIM-3, and LAG-3. Adoptively transferred CD8+ T cells acquired cholesterol, expressed high levels of immune checkpoints, and became exhausted upon entering a tumor. Tumor culture supernatant or cholesterol induced immune checkpoint expression by increasing endoplasmic reticulum (ER) stress in CD8+ T cells. Consequently, the ER stress sensor XBP1 was activated and regulated PD-1 and 2B4 transcription. Inhibiting XBP1 or reducing cholesterol in CD8+ T cells effectively restored antitumor activity. This study reveals a mechanism underlying T cell exhaustion and suggests a new strategy for restoring T cell function by reducing cholesterol to enhance T cell-based immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though both oxidative and ER stress have been shown to contribute to T cell dysfunction across different tumor types (44-51),”
From Bile acid synthesis impedes tumor-specific T cell responses during liver cancer (2025) · cites this paper as [44]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062 · cited 13×
“Tumor-infiltrating CD8+ T cells are associated with progressive loss of effector function due to prolonged antigen exposure and a suppressive tumor microenvironment (Wherry, 2011).”
InfluentialCTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition
Buchbinder, E. I., & Desai, A. (2016) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000239 · Cited by 2,360 · cited 1×
“, the combination of anti-PD-1 with anti-CTLA-4 (Buchbinder and Desai, 2016; Duraiswamy et al., 2013; Dyck and Mills, 2017), anti-PD-1 with anti-TIM-3 (Sakuishi et al.”
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Sakuishi, K., Apetoh, L., Sullivan, J. M., Blazar, B. R., Kuchroo, V. K., & Anderson, A. C. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100643 · Cited by 2,072
Woo, S.-R., Turnis, M. E., Goldberg, M. V., Bankoti, J., Selby, M., Nirschl, C. J., Bettini, M. L., Gravano, D. M., Vogel, P., Liu, C. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1620 · Cited by 1,647
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Boussiotis, V. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1514296 · Cited by 1,372
Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
Angelin, A., Gil‐de‐Gómez, L., Dahiya, S., Jiao, J., Guo, L., Levine, M. H., Wang, Z., Quinn, W. J., Kopinski, P. K., Wang, L., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.018 · Cited by 1,304
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors
Voron, T., Colussi, O., Marcheteau, E., Pernot, S., Nizard, M., Pointet, A.-L., Latreche, S., Bergaya, S., Benhamouda, N., Tanchot, C., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140559 · Cited by 1,179
Statin use and reduced cancer-related mortality
Nielsen, S. F., Nordestgaard, B. G., & Bojesen, S. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201735 · Cited by 1,030
Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
Yang, W., Bai, Y., Xiong, Y., Zhang, J., Chen, S., Zheng, X., Meng, X., Li, L., Wang, J., Xu, C., et al. (2016) · Nature · doi:10.1038/nature17412 · Cited by 1,010
Cited by
Sorted by citations
Items 701–800 of 1,000
T Cell Exhaustion in Allergic Diseases and Allergen Immunotherapy: A Novel Biomarker?
Xu, Q., Li, L., & Zhu, R. (2025) · Current Allergy and Asthma Reports · doi:10.1007/s11882-025-01199-5 · Cited by 7
Halseth, T. A., Mujeeb, A., Liu, L., Banerjee, K., Lang, N., Hollon, T. C., Yu, M., Roest, M. V., Mei, L., He, H., et al. (2025) · Small · doi:10.1002/smll.202307097 · Cited by 5
Self-citationChen, T., Chen, H., Lü, W., & Yao, Y. (2022) · Medicine · doi:10.1097/md.0000000000031307 · Cited by 5
Li, L., Li, Z., He, X., Wang, Y., Lu, M., Gong, T., Chang, Q., Lin, J., Luo, Y., Min, L., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.883308 · Cited by 5
Zhong, M., Huang, Z.-P., Wang, X., Cai, D., Li, C., Gao, F., Wu, X., & Wang, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.902974 · Cited by 5
Sun, Y., Lv, G., Hu, Z., Chen, M., Liu, W., Ikeda-Imafuku, M., Fukuta, T., Kadota, K., Li, X., & Li, E. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.167867 · Cited by 4
Zhao, H., Ma, Y., Tian, F., Li, B., Xiao, N., Mo, X., Aibibula, M., Min, H., Cai, X., Zhang, T., et al. (2023) · Experimental Parasitology · doi:10.1016/j.exppara.2023.108623 · Cited by 4
Self-citationWang, Z., See, X. Y., Chiang, C., Chang, Y.-C., Hsia, Y. P., Chiang, C., Peng, C., & Chiang, C. (2023) · Journal of Chemotherapy · doi:10.1080/1120009x.2023.2290348 · Cited by 4
Xie, X. S., Wang, W., Zhang, H., Zhao, S., Zhang, N., Gao, Y., Liu, Q., & Chen, X. (2025) · BMC Cancer · doi:10.1186/s12885-025-14379-3 · Cited by 4
Han, R., Sun, P., Zhou, M., Xu, W., Hao, X., Peng, Y., Tang, Y., Liu, X., Huang, H. W., Guo, M., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101982 · Cited by 4
Deciphering the MYCN-driven metabolic microenvironment of neuroblastoma
Wolf, A. B., Leardini, D., Li, L., Masetti, R., Lyssiotis, C. A., & Barbieri, E. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.08.005 · Cited by 5
Immunometabolism in cancer: a systemic perspective
Moretti, H., Cioccoloni, G., & Perucha, E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1656776 · Cited by 4
Shi, K., Pan, B., Zheng, R., Liu, K., Song, J., Wang, X., & Li, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1696102 · Cited by 4
Liang, X.-J., Guo, X., Zhu, P.-H., Zhao, Z., You, Z., Yang, K., Song, Y., Li, L., & Song, X. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02436 · Cited by 4
The Diverse Roles of Lipid Metabolism Reprogramming in Shaping the Tumor Immune Microenvironment
Lee, J., Cheu, J. W., & Wong, C. C. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-2568 · Cited by 4
Liu, Z., Shen, X., Lu, Q., Qin, S., Zeng, F., He, B., Han, X., Wang, Y., Wang, M., & Song, Y. (2026) · ACS Nano · doi:10.1021/acsnano.5c20175 · Cited by 4
Xie, J., Xiao, Y.-Y., Peng, B., Chen, X., Zhang, X., Chen, D., Song, L., Xu, M., Liao, W., & Zhang, X. (2026) · Chemical Communications · doi:10.1039/d5cc06431g · Cited by 4
Feng, X., Zhang, Y., Bajinka, O., Ouédraogo, S. Y., Zhang, Y., Li, N., & Zhan, X. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02050-9 · Cited by 4
Exercise and CD8+ T cells: mechanisms of immune modulation in antitumor responses
Liu, L., Deng, Z., Fang, R., Zou, M., Ren, J., Gao, Y., Peng, J., & Hao, L. (2026) · Journal of Molecular Medicine · doi:10.1007/s00109-026-02659-9 · Cited by 4
Self-citationZhao, Y., Shang, Y., Luan, T., Yu, Z., Yang, Y., Niu, X., Li, H., Wang, S., Wang, C., & Liu, L. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02674-x · Cited by 4
Self-citationCholesterol metabolism in immune cells: From mechanisms to therapeutic opportunities
Yin, M., Liang, T., Zhang, Y., Wang, G., Yang, W., & Xu, C. (2026) · Immunity · doi:10.1016/j.immuni.2026.05.007 · Cited by 5
Yang, Y., Luo, D., Gao, W., Wang, Q., Yao, W., Xue, D., & Ma, B. (2023) · Biomolecules · doi:10.3390/biom13010147 · Cited by 4
Self-citationYin, D., Zhang, Y., Li, H., & Cheng, L. (2023) · The Clinical Respiratory Journal · doi:10.1111/crj.13717 · Cited by 4
Serum cholesterol level as a predictive biomarker for prognosis of Neuroblastoma
Min, J., Wu, Y.-F., Huang, S., Li, Y., Lv, X., Tang, R., Zhao, H., & Wang, J. (2024) · BMC Pediatrics · doi:10.1186/s12887-024-04700-7 · Cited by 4
Choi, H.-J., Wu, Y., Mims, B. M., Pugel, A., Tang, C.-H. A., Tian, L., Hu, C. A., & Yu, X. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300616 · Cited by 4
Multifunctional Nanomaterials Mediate Cholesterol Depletion for Cancer Treatment
Zhen, W., Germanas, T., Weichselbaum, R. R., & Lin, W. (2024) · Angewandte Chemie · doi:10.1002/ange.202412844 · Cited by 4
Liu, Z., Liu, Q., Zeng, A., & Song, L. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114024 · Cited by 4
Ju, S. H., & Ku, B. J. (2022) · Medicine · doi:10.1097/md.0000000000031691 · Cited by 4
Zhan, J., Zhang, M., Zhou, L., & He, C. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1065773 · Cited by 4
[Latest Findings on the Function of Immune Metabolism in Tumor Immunity].
Yang, Y., Fan, D., Zheng, B.-H., & Zhou, S. (2023) · 四川大学学报：医学版 · doi:10.12182/20230560304 · Cited by 4
Shi, Y., Du, J., Pan, W., Zhang, H., & Ba, Y. (2023) · journal of nutritional oncology · doi:10.1097/jn9.0000000000000008 · Cited by 5
Instruction of Immunometabolism by Adipose Tissue: Implications for Cancer Progression
Raja, R., Wu, C. W., Limbeck, F., Butler, K. A., Acharya, A. P., & Curtis, M. (2021) · Cancers · doi:10.3390/cancers13133327 · Cited by 4
Transcription factor collaboration enables precise T cell state engineeringPreprint
Savage, R. E., Amador, C. D. M., Hock, C., Zhang, R., Kuo, H., Gao, A., Horlbeck, M. A., Gersbach, C. A., & Buenrostro, J. D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.20.718569 · Cited by 5
Kavran, A. J., Bai, Y., Rabe, B. A., Kreshock, A., Fisher, A., Cheng, Y., Lewin, A. C., Dai, C., Meyer, M. J., Mavrakis, K. J., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1549237 · Cited by 3
Serum metabolomics to identify molecular subtypes and predict XELOX efficacy in colorectal cancer
Zhang, Y., Ye, L., Qin, Y., Qiu, C., Sun, Q., Fan, T., Chen, Y., & Jiang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-97463-9 · Cited by 3
Lu, X. Y., Guo, R., Wang, M., Sun, L., Song, Z., Zhang, Z., Wang, B., & Zhang, H. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.163523 · Cited by 3
Yan, K., Zhang, W., Chu, W., Qi, J., Song, H., & Xu, X. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02597-4 · Cited by 3
Wang, Z., Li, X., & Sun, X. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189422 · Cited by 2
Ether-lipids accumulation promotes hepatocellular carcinoma progression linked to PPARα deficiency
Liao, P.-Y., Lin, W.-J., Shen, P.-C., Yang, C.-R., Yu, Y., Yeh, C.-C., Jeng, L., Lai, H.-C., Cheng, W., & Ma, W. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01178-y · Cited by 3
NPC1 as a novel therapeutic target for induction of pyroptosis in cancers
Zhang, C., Wang, Q., Su, P., Qian, J., Guo, Q., Wu, W., Duan, R., Zhang, Y.-F., Zu, Y., Zhong, L., et al. (2025) · Biomarker Research · doi:10.1186/s40364-025-00823-w · Cited by 3
Self-citation2B4/CD244 Signaling in Immune Regulation and Its Role in Infection, Cancer, and Immune Tolerance
Yan, C., Lu, P., Jiang, Y., Miao, S., Zhao, L., & Xu, X. (2025) · ImmunoTargets and Therapy · doi:10.2147/itt.s538126 · Cited by 3
Chen, H., Qi, Z., Wang, D., Zhao, D., & Li, F. (2025) · South African Journal of Botany · doi:10.1016/j.sajb.2025.10.021 · Cited by 3
Williams, M., Joffe, D., Mandel, J. L., Schepps, S., Wallace, M., Portocarrero, C. P., Abinader, O., Mitra, R., Mishra, A., & Nikbakht, N. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.11.013 · Cited by 3
Wang, Y., Wu, Y., Shen, Y., Chen, Y., Zhao, Y., Zeng, X., & He, K. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101965 · Cited by 3
Gong, Z., Chen, K., Luo, A., Zhang, J., Yi, H., Xie, X., Dai, K., Lu, Z., & Xie, Y. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01508 · Cited by 3
Markovska, A., Lommers, L. F., Bodelόn, A., Greve, P. F., der Zee, L. C. V. V., Mulder, M. T., Lennep, J. R. V., Zelcer, N., Schipper, H. S., & Boes, M. L. (2026) · iScience · doi:10.1016/j.isci.2026.114859 · Cited by 3
Yang, L., Zhang, C., Zhang, Z., Yao, S., Shen, J., Zhang, Z., Xiao, Z., Wang, S., & Wu, Z. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07887-8 · Cited by 3
Zheng, R., Cui, Y., Hu, X., Dong, X., Meng, B., Wen, L., Chen, A., Wang, Z., Qiang, G., Cheng, S., et al. (2026) · MedComm · doi:10.1002/mco2.70657 · Cited by 3
Ding, Y., Fang, W., Xiang, R., Liu, H., Huang, M., Shen, Y., Chen, Y., Wang, G., Zhou, Z., Ling, Y., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69305-3 · Cited by 3
Elsheikh, M., Ibrahim, M. A., Fares, S., Bhongade, M., Adhem, K., Ramirez-Morales, X. I., Kaseb, A. O., Petrosino, J. F., Hassan, M. M., & Jalal, P. K. (2026) · Cancer Medicine · doi:10.1002/cam4.71738 · Cited by 3
Citraconate preserves T cell stemness and antitumor immunity
Li, W., Ge, M., Luo, Z., Ni, M., Tang, K., Han, C., J, Y., Ma, Y., Liu, X., Ma, K., et al. (2026) · Science Immunology · doi:10.1126/sciimmunol.adz0348 · Cited by 3
Gao, Y., Gong, Y., Du, Z., Zhang, W., Lai, L., Lan, M., Jia, Z., Song, X., Xiong, Y., Gong, Y., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158584 · Cited by 3
Overcoming T-cell exhaustion in glioblastoma
Wang, X., Wang, X., & Li, J. (2022) · Glioma · doi:10.4103/glioma.glioma_16_22 · Cited by 3
Tao, R. X., Huang, R., Yang, J., Wang, J., Wang, K., Han, B., & Wang, K. (2023) · BMC Cancer · doi:10.1186/s12885-023-10897-0 · Cited by 3
Li, C., Xiong, Z., Han, J., Nian, W., Wang, Z., Cai, K., Gao, J., Wang, G., Tao, K., & Cai, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-52647-7 · Cited by 3
Crosstalk between thyroid CSCs and immune cells: basic principles and clinical implications
Li, X., Han, H., Yang, K., Li, S., Ma, L., Yang, Z. R., & Zhao, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1476427 · Cited by 3
Baldwin, J., Silveira, C. R. F., & Gattinoni, L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02151-9 · Cited by 3
Ji, Y., Jiang, J., Hu, L., Peng, L., Zhou, M., Hu, S., Wang, M., Ji, Y., Liu, X., Yan, D., et al. (2025) · Cell Research · doi:10.1038/s41422-025-01155-y · Cited by 3
Muddather, H. F., Bózsity, N., Balogh, G. T., Schelz, Z., & Zupkó, I. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101253 · Cited by 3
Huang, T., Shan, R., Zhang, M., Li, L., Huang, J., Liu, B., & Zhou, W. (2021) · PubMed Central · doi:10.7507/1001-5515.202105008 · Cited by 3
Yuan, Y., Song, J., & Wu, Q. (2022) · Medicine · doi:10.1097/md.0000000000031416 · Cited by 3
Role of Various Immune Cells in the Tumor Microenvironment
Bhargav, A., Bhalla, N., Manoharan, S., Gurbind, S., Sandeep, K. Y., & Aloukick, K. S. (2023) · Diseases & Research · doi:10.54457/dr.202301006 · Cited by 3
Hu, S., Duan, H., Lu, Y., & Huang, S. (2023) · Discover Oncology · doi:10.1007/s12672-023-00806-z · Cited by 3
Self-citationHu, Z., Zheng, Y., Zheng, J., Wang, Y., Liao, J., Liu, Z., Li, J., & Cui, H. (2024) · Cancer Medicine · doi:10.1002/cam4.7241 · Cited by 3
Li, J., Wang, J., & Cao, B. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1448966 · Cited by 3
Löffler, L., Mashkoor, M., Gögenür, I., & Gögenur, M. (2024) · International Journal of Colorectal Disease · doi:10.1007/s00384-024-04735-3 · Cited by 3
Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials
Zhang, H., Rutkowska, A., González-Martı́n, A., Mirza, M. R., Monk, B. J., Vergote, I. B., Pothuri, B., Graybill, W. A. S., Goessel, C., Barbash, O., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0191 · Cited by 3
SEC14L2 regulates the transport of cholesterol in non-small cell lung cancer through SCARB1
Zhou, Q., Li, D., Liang, Y., Long, Y., & Liu, Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02401-9 · Cited by 3
Gu, W., Mo, S., Wang, Y., Kawabata‐Iwakawa, R., Zhang, W., Yang, Z., Sun, C., Tsushima, Y., Xu, H., & Nakajima, T. (2022) · Cancers · doi:10.3390/cancers14071825 · Cited by 3
Nuclear Receptors and Lipid Sensing
Thorne, J. L., & Cioccoloni, G. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11836-4_5 · Cited by 3
Qian, L., Zhou, C., Wang, K., Li, L., Xia, W., & Yuan, F. (2023) · International Journal of Genomics · doi:10.1155/2023/9708282 · Cited by 3
Quinidine dosage in children using population estimates.
Burckart, G. J., & Marı́n-Garcı́a, J. (1986) · PubMed · Cited by 3
Palaniyandi, T., Sivaji, A., Natarajan, S., Ravi, M., & Viswanathan, S. (2024) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-024-03262-3 · Cited by 2
Zhu, C., Yan, M., Zhang, Z., Shen, Y., Wang, W., Chen, Z., Cai, C., Liu, H., Xu, Z., & Li, Z. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1518010 · Cited by 2
Gao, Q., Cui, Y., Gao, F., Yang, Y., Huangfu, W., & Wang, M. (2025) · Medicine · doi:10.1097/md.0000000000041797 · Cited by 2
Lin, Y.-L., & Wang, C.-R. (2025) · Mucosal Immunology · doi:10.1016/j.mucimm.2025.04.009 · Cited by 2
Hou, M., Ji, L., Li, D., Xiao, Q., & Hu, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-00586-2 · Cited by 2
Huang, D., Liu, Y., Yuan, M., Wang, X., & Hong, L. (2025) · Discover Oncology · doi:10.1007/s12672-025-03033-w · Cited by 2
Non-Coding RNAs as Critical Modulators of Cholesterol Metabolism in Cancer
Zhang, C., Miao, Z., Xu, Y., & Shi, T. (2025) · Biomedicines · doi:10.3390/biomedicines13071631 · Cited by 2
Tiwary, S., Hsu, K. S., Goldfarbmuren, K. C., Xia, Z., & Berzofsky, J. A. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0927 · Cited by 2
Jiang, Q. L., Tang, Y.-X., & Zhou, G. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115457 · Cited by 2
Popescu, S. N., Milligan, K., Wiebe, M., Fuentes, A. M., Brewer, J. M., Haston, C. K., Lum, J. J., Punch, S., Raudales, A., Brolo, A. G., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-20107-5 · Cited by 2
Wang, J., Xiong, J., Guo, H., Li, Z., Cao, Y., Fang, Y., Liu, Y., Li, Y., Cai, J., Zhang, Y., et al. (2025) · Annals of Hematology · doi:10.1007/s00277-025-06724-0 · Cited by 2
Qu, D., Bai, Y., Liu, X., Cao, Y. Z., Li, W., Wang, Z., Bai, S., Zhang, S., Wang, B., Yang, S., et al. (2025) · Angewandte Chemie · doi:10.1002/ange.202516348 · Cited by 2
Rethinking the microenvironment’s role in chemical-induced malignancy
Bisson, W. H., Currie, R. A., Lim, E. L., Mlynarczyk, C., Tokar, E. J., Colacci, A., & Colacino, J. A. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf174 · Cited by 2
Liver-X-receptor agonism enhances T cell priming and activation to promote anti-tumor immunity
Ostendorf, B. N., Goldstein, J. G., Liu, S., Gonsalves, F. C., Bilanovic, J., Yuan, M., Kim, J.-Y., Rouya, C., Tavazoie, M. F., & Tavazoie, S. F. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20252290 · Cited by 2
Drug repurposing in oncology: Bridging computational discovery to clinical application
Baskar, S., & Prasad, N. R. (2026) · International Journal of Cancer · doi:10.1002/ijc.70429 · Cited by 2
Lipid metabolic reprogramming of CD8+ T cells in the tumor microenvironment
Mao, L., Zou, J., Jin, H., Liao, W., Li, Y., & Wu, D. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112496 · Cited by 2
CD8+ T cell exhaustion driven by metabolic reprogramming
Deng, W., Li, C., Wang, Q., Jiang, X., & Xie, Y. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04287-2 · Cited by 2
Self-citationZhao, S., Zhang, J., Mi, Y., Quan, B., Hu, Z., Zhong, X., Xu, Y., Cai, S., Li, X., Wei, P., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71403-1 · Cited by 2
Yang, L., Sheng, J., Qi, S., Yin, Z., Chan, M., Cao, Y., Zhao, H., Wan, Z., Chan, B., Ahn, J. Y., et al. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00943-3 · Cited by 2
Pan, Y., Hu, X., & Cheng, J. (2026) · Discover Oncology · doi:10.1007/s12672-026-05070-5 · Cited by 2
Shang, Y., Yang, Q., Zhang, R., Xu, W., EL-Aty, A. M. A., Gao, Y., & Wang, T. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02956-9 · Cited by 2
Zhai, Y., Yu, Y., Bao, R., Liu, J., Fang, J., Lu, W., Zhang, D., Guo, H., Yao, Y., & Shi, J. (2026) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-026-04397-w · Cited by 2
Wang, M., Dong, W., Chen, J., Zhou, Z., Fu, S., Wu, T., Jiang, H., Wang, Z., Zhong, Z., & Zhong, Y. (2026) · Advanced Science · doi:10.1002/advs.75651 · Cited by 2
Cholesterol as a metabolic integrator of oncogenic signaling, immune evasion, and therapy resistance
Skossyrskiy, V. S., Prozorenko, E., Gadaev, I., Skossyrskiy, A., Orlova, E. V., & Sekacheva, M. I. (2026) · APOPTOSIS · doi:10.1007/s10495-026-02351-w · Cited by 2
Systemic health impact of cancer-associated extracellular vesicles and particles
Wang, G., Lucotti, S., Bojmar, L., Tobias, G. C., Piszczatowski, R. T., Dror, S., Zhang, H., & Lyden, D. C. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00952-w · Cited by 2
Wei, J., Yu, B., Wang, N., Huang, X., Su, S., Chen, Z., Hu, M., Wen, X., Liang, J., Shao, L., et al. (2026) · Discover Oncology · doi:10.1007/s12672-026-05474-3 · Cited by 2
Lipids in ovarian cancer ascites impair T cell activation by disrupting TCR dynamics
Brown, E. G., Compeer, E. B., Gan, Z., Kelly, A. R., Shestov, A. A., Córdoba-Espejo, L., Evans, M. T., Liu, A. Y., Naughton, N. H., Parnaik, T. S., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01557-1 · Cited by 2
Cholesterol induces inflammation and reduces glucose utilization
Hong, P., Wang, Q., & Chen, G. (2023) · Open Medicine · doi:10.1515/med-2023-0701 · Cited by 2
Self-citation
Metadata
- Authors
- Ma, X., Bi, E., Lu, Y., Su, P., Huang, C., Liu, L., Wang, Q., Yang, M., Kalady, M. F., Qian, J., Zhang, A., Gupte, A. A., Hamilton, D. J., Zheng, C., & Yi, Q.
- Affiliations
- Houston Methodist (US)
- Wake Forest University Health Sciences (US)
- Cleveland Clinic (US)
- Houston Methodist Research Institute (US)
- Second Hospital of Shandong University (CN)
- Corresponding author
- Yi, Qing
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 30
- Issue
- 1
- Pages
- 143-156.e5
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC7061417
- OpenAlex
- W2941036215
- Cited by
- 1,033
- References
- 45
- Citations by year
- 2026: 176 · 2025: 204 · 2024: 187 · 2023: 169 · 2022: 136 · 2021: 100 · 2020: 47 · 2019: 12
- FWCI
- 31.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- cholesterol, CD8+ T cell exhaustion, tumor microenvironment, immune checkpoint, PD-1, 2B4, TIM-3, LAG-3, endoplasmic reticulum stress, XBP1, adoptive T cell therapy, antitumor immunity, cholesterol metabolism
- MeSH terms
- Animals, Cholesterol, Flow Cytometry, Humans, Immunotherapy, Melanoma, Experimental, Blotting, Western, CD8-Positive T-Lymphocytes, Immunoprecipitation, Mice, Tumor Microenvironment, Real-Time Polymerase Chain Reaction, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
